Cognitive functions in neuromyelitis optica

Archives of Neurology

Volumn 65, Issue 1, 2008, Pages 84-88

  Blanc, Frédéric ^a   Zéphir, Hélène ^b   Lebrun, Christine ^c   Labauge, Pierre ^d   Castelnovo, Giovanni ^d   Fleury, Marie ^a   Sellal, François ^a   Tranchant, Christine ^a   Dujardin, Kathy ^b   Vermersch, Patrick ^b   De Seze, Jérôme ^a,e  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d University of Nimes   (France)

^e HÔPITAL CIVIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; BLINDNESS; COGNITION; COGNITION DISORDERS; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MEMORY; MENTAL RECALL; MIDDLE AGED; NEUROMYELITIS OPTICA; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; WECHSLER SCALES;

EID: 38349052183     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2007.16     Document Type: Article

References (26)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-2112.
2. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of opticspinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473-477.
3. Nagelhus EA, Veruki ML, Torp R, et al. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Muller cells and fibrous astrocytes. J Neurosci. 1998;18(7):2506-2519.
4. Vitellaro-Zuccarello L, Mazzetti S, Bosisio P, Monti C, De Biasi S. Distribution of Aquaporin 4 in rodent spinal cord: relationship with astrocyte markers and chondroitin sulfate proteoglycans. Glia. 2005;51(2):148-159.
5. Venero JL, Vizuete ML, Ilundain AA, Machado A, Echevarria M, Cano J. Detailed localization of aquaporin-4 messenger RNA in the CNS: preferential expression in periventricular organs. Neuroscience. 1999;94(1):239-250.
6. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63(3):390-396.
7. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63(7):964-968.
8. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107-1114.
9. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-1489.
10. Rubiera M, Rio J, Tintore M, et al. Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis. Neurology. 2006;66(10):1568-1570.
11. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: impact on employment and social functioning. Neurology. 1991;41(5):692-696.
12. Dujardin K, Sockeel P, Cabaret M, de Seze J, La Vermersch P. BCcogSEP: une batterie courte des fonctions cognitives destinée aux patients souffrant de sclérose en plaques. Rev Neurol (Paris). 2004;160(1):51-62.
13. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67(3):588-597.
14. Nakamura M, Endo M, Murakami K, Konno H, Fujihara K, Itoyama Y. An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler. 2005;11(6):735-738.
15. Chalumeau-Lemoine L, Chretien F, Si Larbi AG, et al. Devic disease with brain-stem lesions. Arch Neurol. 2006;63(4):591-593.
16. Misu T, Fujihara K, Nakamura M, et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med. 2006;209(3):269-275.
17. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996;60(4):382-387.
18. de Seze J, Stojkovic T, Ferriby D, et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci. 2002;197(1-2):57-61.
19. de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, Vermersch P. Is Devic's neuromyelitis optica a separate disease? a comparative study with multiple sclerosis. Mult Scler. 2003;9(5):521-525.
20. Rocca MA, Agosta F, Mezzapesa DM, et al. Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology. 2004;62(3):476-478.
21. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125(pt 7):1450-1461.
22. Rao SM. Neuropsychology of multiple sclerosis. Curr Opin Neurol. 1995;8(3):216-220.
23. Ciccarelli O, Brex PA, Thompson AJ, Miller DH. Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR. J Neurol. 2002;249(1):18-24.
24. Hildebrandt H, Hahn HK, Kraus JA, Schulte-Herbruggen A, Schwarze B, Schwendemann G. Memory performance in multiple sclerosis patients correlates with central brain atrophy. Mult Scler. 2006;12(4):428-436.
25. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998;51(4):1219-1220.
26. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64(7):1270-1272.